Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lucie Biard

Showing results (81-90 of 85) with videos related to

Pageof 9
Sort By:
You have reached the last page of results.This site can display upto 85 results.
American Journal of Ophthalmology|February 5, 2026
Adalimumab, Anakinra and Tocilizumab in patients with non-infectious Uveitis: A multicenter randomized controlled trialDavid Saadoun, Amine Ghembaza, Sarah Touhami, et al.
Chest|August 8, 2020
Outcomes in 886 Critically Ill Patients After Near-Hanging InjuryLouise de Charentenay, Guillaume Schnell, Nicolas Pichon, et al.
Rheumatology (Oxford, England)|August 7, 2021
Efficacy and safety of TNF-α antagonists and tocilizumab in Takayasu arteritis: multicentre retrospective study of 209 patientsArsène Mekinian, Lucie Biard, Lorenzo Dagna, et al.
RMD Open|June 15, 2023
Intravenous versus subcutaneous tocilizumab in Takayasu arteritis: multicentre retrospective studyArsène Mekinian, Lucie Biard, Dagna Lorenzo, et al.
Rheumatology (Oxford, England)|August 14, 2025
Effectiveness of intravenous infliximab versus subcutaneous adalimumab in Takayasu arteritis: multicenter retrospective studyArsène Mekinian, Sarah Meneses, Lucie Biard, et al.
Pageof 9

Showing results (81-90 of 85) with videos related to

Sort By:
Pageof 9
You have reached the last page of results.This site can display upto 85 results.
American Journal of Ophthalmology|February 5, 2026
Adalimumab, Anakinra and Tocilizumab in patients with non-infectious Uveitis: A multicenter randomized controlled trialDavid Saadoun, Amine Ghembaza, Sarah Touhami, et al.
Chest|August 8, 2020
Outcomes in 886 Critically Ill Patients After Near-Hanging InjuryLouise de Charentenay, Guillaume Schnell, Nicolas Pichon, et al.
Rheumatology (Oxford, England)|August 7, 2021
Efficacy and safety of TNF-α antagonists and tocilizumab in Takayasu arteritis: multicentre retrospective study of 209 patientsArsène Mekinian, Lucie Biard, Lorenzo Dagna, et al.
RMD Open|June 15, 2023
Intravenous versus subcutaneous tocilizumab in Takayasu arteritis: multicentre retrospective studyArsène Mekinian, Lucie Biard, Dagna Lorenzo, et al.
Rheumatology (Oxford, England)|August 14, 2025
Effectiveness of intravenous infliximab versus subcutaneous adalimumab in Takayasu arteritis: multicenter retrospective studyArsène Mekinian, Sarah Meneses, Lucie Biard, et al.
Pageof 9